Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2020 2
2021 3
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
HER3 Alterations in Cancer and Potential Clinical Implications.
Kilroy MK, Park S, Feroz W, Patel H, Mishra R, Alanazi S, Garrett JT. Kilroy MK, et al. Among authors: alanazi s. Cancers (Basel). 2022 Dec 14;14(24):6174. doi: 10.3390/cancers14246174. Cancers (Basel). 2022. PMID: 36551663 Free PMC article. Review.
Current Advances in the Treatment of BRAF-Mutant Melanoma.
Patel H, Yacoub N, Mishra R, White A, Long Y, Alanazi S, Garrett JT. Patel H, et al. Among authors: alanazi s. Cancers (Basel). 2020 Feb 19;12(2):482. doi: 10.3390/cancers12020482. Cancers (Basel). 2020. PMID: 32092958 Free PMC article. Review.
Activating HER3 mutations in breast cancer.
Mishra R, Alanazi S, Yuan L, Solomon T, Thaker TM, Jura N, Garrett JT. Mishra R, et al. Among authors: alanazi s. Oncotarget. 2018 Jun 12;9(45):27773-27788. doi: 10.18632/oncotarget.25576. eCollection 2018 Jun 12. Oncotarget. 2018. PMID: 29963236 Free PMC article.
HER3 signaling and targeted therapy in cancer.
Mishra R, Patel H, Alanazi S, Yuan L, Garrett JT. Mishra R, et al. Among authors: alanazi s. Oncol Rev. 2018 May 16;12(1):355. doi: 10.4081/oncol.2018.355. eCollection 2018 Jan 30. Oncol Rev. 2018. PMID: 30057690 Free PMC article.
Phosphoinositide 3-Kinase (PI3K) Reactive Oxygen Species (ROS)-Activated Prodrug in Combination with Anthracycline Impairs PI3K Signaling, Increases DNA Damage Response and Reduces Breast Cancer Cell Growth.
Mishra R, Yuan L, Patel H, Karve AS, Zhu H, White A, Alanazi S, Desai P, Merino EJ, Garrett JT. Mishra R, et al. Among authors: alanazi s. Int J Mol Sci. 2021 Feb 19;22(4):2088. doi: 10.3390/ijms22042088. Int J Mol Sci. 2021. PMID: 33669867 Free PMC article.
11 results